Helix Depreciation And Amortization vs Non Recurring Analysis

HBP Stock  CAD 0.87  0.07  7.45%   
Helix BioPharma financial indicator trend analysis is much more than just examining Helix BioPharma Corp latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Helix BioPharma Corp is a good investment. Please check the relationship between Helix BioPharma Depreciation And Amortization and its Non Recurring accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Helix BioPharma Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Depreciation And Amortization vs Non Recurring

Depreciation And Amortization vs Non Recurring Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Helix BioPharma Corp Depreciation And Amortization account and Non Recurring. At this time, the significance of the direction appears to have weak relationship.
The correlation between Helix BioPharma's Depreciation And Amortization and Non Recurring is 0.32. Overlapping area represents the amount of variation of Depreciation And Amortization that can explain the historical movement of Non Recurring in the same time period over historical financial statements of Helix BioPharma Corp, assuming nothing else is changed. The correlation between historical values of Helix BioPharma's Depreciation And Amortization and Non Recurring is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Depreciation And Amortization of Helix BioPharma Corp are associated (or correlated) with its Non Recurring. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Non Recurring has no effect on the direction of Depreciation And Amortization i.e., Helix BioPharma's Depreciation And Amortization and Non Recurring go up and down completely randomly.

Correlation Coefficient

0.32
Relationship DirectionPositive 
Relationship StrengthVery Weak

Depreciation And Amortization

The systematic reduction in the recorded value of an intangible asset. This includes the allocation of the cost of tangible assets to periods in which the assets are used, representing the expense related to the wear and tear, deterioration, or obsolescence of physical assets and intangible assets over their useful lives.

Non Recurring

Most indicators from Helix BioPharma's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Helix BioPharma Corp current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Helix BioPharma Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
At this time, Helix BioPharma's Discontinued Operations is very stable compared to the past year. As of the 12th of December 2024, Sales General And Administrative To Revenue is likely to grow to 1.36, while Selling General Administrative is likely to drop about 2.8 M.
 2023 2024 (projected)
Minority Interest117K111.2K
Reconciled Depreciation14K13.3K

Helix BioPharma fundamental ratios Correlations

-0.07-0.490.960.76-0.950.87-0.510.990.720.990.75-0.690.030.77-0.14-0.16-0.41-0.181.00.130.950.7-0.620.810.54
-0.07-0.05-0.010.17-0.040.130.07-0.120.16-0.120.050.03-0.440.26-0.220.48-0.140.07-0.090.070.090.26-0.220.240.19
-0.49-0.05-0.7-0.430.66-0.470.75-0.48-0.4-0.48-0.290.280.4-0.230.260.350.960.23-0.48-0.23-0.65-0.120.1-0.3-0.33
0.96-0.01-0.70.76-0.980.86-0.640.940.720.940.7-0.64-0.10.71-0.16-0.21-0.64-0.210.950.180.980.64-0.580.770.55
0.760.17-0.430.76-0.730.91-0.220.650.980.650.88-0.78-0.190.84-0.33-0.19-0.43-0.340.70.180.780.58-0.50.820.71
-0.95-0.040.66-0.98-0.73-0.850.53-0.94-0.67-0.94-0.650.650.18-0.680.180.150.620.3-0.95-0.17-0.97-0.670.6-0.79-0.49
0.870.13-0.470.860.91-0.85-0.310.810.840.810.9-0.9-0.080.74-0.37-0.2-0.45-0.470.840.280.860.62-0.520.870.65
-0.510.070.75-0.64-0.220.53-0.31-0.55-0.23-0.55-0.230.1-0.14-0.23-0.050.230.66-0.26-0.53-0.1-0.61-0.160.14-0.16-0.22
0.99-0.12-0.480.940.65-0.940.81-0.550.61.00.66-0.640.070.67-0.1-0.15-0.4-0.161.00.10.930.67-0.590.750.43
0.720.16-0.40.720.98-0.670.84-0.230.60.60.85-0.71-0.190.87-0.32-0.22-0.4-0.260.650.120.730.52-0.450.740.72
0.99-0.12-0.480.940.65-0.940.81-0.551.00.60.66-0.640.070.67-0.1-0.15-0.4-0.161.00.10.930.67-0.590.750.43
0.750.05-0.290.70.88-0.650.9-0.230.660.850.66-0.870.150.73-0.3-0.2-0.25-0.370.70.470.710.54-0.450.770.82
-0.690.030.28-0.64-0.780.65-0.90.1-0.64-0.71-0.64-0.87-0.05-0.510.430.40.270.7-0.66-0.34-0.61-0.340.23-0.67-0.56
0.03-0.440.4-0.1-0.190.18-0.08-0.140.07-0.190.070.15-0.05-0.090.460.060.420.270.060.22-0.11-0.010.04-0.080.07
0.770.26-0.230.710.84-0.680.74-0.230.670.870.670.73-0.51-0.09-0.120.17-0.210.040.720.030.770.78-0.710.830.68
-0.14-0.220.26-0.16-0.330.18-0.37-0.05-0.1-0.32-0.1-0.30.430.46-0.120.410.140.39-0.11-0.1-0.15-0.010.01-0.17-0.19
-0.160.480.35-0.21-0.190.15-0.20.23-0.15-0.22-0.15-0.20.40.060.170.410.260.42-0.140.02-0.090.46-0.420.240.0
-0.41-0.140.96-0.64-0.430.62-0.450.66-0.4-0.4-0.4-0.250.270.42-0.210.140.260.3-0.4-0.23-0.61-0.120.1-0.3-0.33
-0.180.070.23-0.21-0.340.3-0.47-0.26-0.16-0.26-0.16-0.370.70.270.040.390.420.3-0.16-0.38-0.140.1-0.15-0.24-0.23
1.0-0.09-0.480.950.7-0.950.84-0.531.00.651.00.7-0.660.060.72-0.11-0.14-0.4-0.160.130.940.7-0.620.780.49
0.130.07-0.230.180.18-0.170.28-0.10.10.120.10.47-0.340.220.03-0.10.02-0.23-0.380.130.150.1-0.080.260.7
0.950.09-0.650.980.78-0.970.86-0.610.930.730.930.71-0.61-0.110.77-0.15-0.09-0.61-0.140.940.150.73-0.670.830.54
0.70.26-0.120.640.58-0.670.62-0.160.670.520.670.54-0.34-0.010.78-0.010.46-0.120.10.70.10.73-0.980.890.46
-0.62-0.220.1-0.58-0.50.6-0.520.14-0.59-0.45-0.59-0.450.230.04-0.710.01-0.420.1-0.15-0.62-0.08-0.67-0.98-0.81-0.41
0.810.24-0.30.770.82-0.790.87-0.160.750.740.750.77-0.67-0.080.83-0.170.24-0.3-0.240.780.260.830.89-0.810.63
0.540.19-0.330.550.71-0.490.65-0.220.430.720.430.82-0.560.070.68-0.190.0-0.33-0.230.490.70.540.46-0.410.63
Click cells to compare fundamentals

Helix BioPharma Account Relationship Matchups

Helix BioPharma fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets4.9M4.1M3.7M1.0M1.5M1.4M
Other Current Liab350K380K344K1.4M724K569.3K
Total Current Liabilities1.9M3.9M3.4M1.9M1.6M2.2M
Total Stockholder Equity2.4M(1.4M)319K(844K)(90K)(85.5K)
Property Plant And Equipment Net246K47K35K33K29.7K28.2K
Net Debt(4.1M)47K(784K)(808K)(1.1M)(1.1M)
Retained Earnings(180.5M)(188.6M)(195.1M)(201.4M)(210.7M)(221.2M)
Accounts Payable1.4M1.5M599K493K855K1.1M
Cash4.2M3.6M3.3M808K1.1M1.0M
Non Current Assets Total246K47K35K33K29.7K28.2K
Cash And Short Term Investments4.2M3.6M3.3M808K1.1M1.0M
Net Receivables180K353K280K62K54K51.3K
Common Stock Shares Outstanding25.5M27.6M29.9M38.6M44.5M46.7M
Liabilities And Stockholders Equity4.9M4.1M3.7M1.0M1.5M1.4M
Other Current Assets245K100K443K126K321K203.3K
Other Stockholder Equity25.5M27.9M37.6M48.5M52.0M31.7M
Total Liab1.9M5.5M3.4M1.9M1.6M2.4M
Property Plant And Equipment Gross246K1.8M1.8M1.8M1.8M1.9M
Total Current Assets4.7M4.0M3.7M996K1.5M1.4M
Accumulated Other Comprehensive Income20.1M19.6M10.3M4.4M5.0M2.8M
Net Tangible Assets(3.3M)2.4M(1.4M)319K287.1K272.7K
Property Plant Equipment246K47K36K33K29.7K28.2K
Non Currrent Assets Other(3.0)(1.0)0.01K900.0855.0
Common Stock137.3M139.7M147.5M152.1M158.6M131.0M
Capital Surpluse25.5M27.9M37.6M44.1M50.8M29.9M
Current Deferred Revenue38K124K301K345K396.8K416.6K
Net Invested Capital2.4M2.2M2.8M(844K)(90K)(85.5K)
Net Working Capital2.7M144K284K(878K)(123K)(129.2K)
Capital Stock137.3M139.7M147.5M152.1M158.6M155.6M

Pair Trading with Helix BioPharma

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Helix BioPharma position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Helix BioPharma will appreciate offsetting losses from the drop in the long position's value.

Moving against Helix Stock

  0.79RY-PM Royal BankPairCorr
  0.74RY-PS Royal BankPairCorr
  0.73TD-PFI Toronto Dominion BankPairCorr
  0.67BNS Bank of Nova ScotiaPairCorr
  0.67TD-PFD Toronto Dominion BankPairCorr
The ability to find closely correlated positions to Helix BioPharma could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Helix BioPharma when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Helix BioPharma - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Helix BioPharma Corp to buy it.
The correlation of Helix BioPharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Helix BioPharma moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Helix BioPharma Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Helix BioPharma can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Other Information on Investing in Helix Stock

Balance Sheet is a snapshot of the financial position of Helix BioPharma Corp at a specified time, usually calculated after every quarter, six months, or one year. Helix BioPharma Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Helix BioPharma and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Helix currently owns. An asset can also be divided into two categories, current and non-current.